Mechanism of neuromuscular blockade induced by phenthonium, a quaternary derivative of (-)-hyoscyamine, in skeletal muscles

Detalhes bibliográficos
Autor(a) principal: Souccar, Caden [UNIFESP]
Data de Publicação: 1998
Outros Autores: Lima-Landman, MTR, Ballejo, G., Lapa, Antonio José [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/handle/11600/25917
http://dx.doi.org/10.1038/sj.bjp.0701932
Resumo: 1 the mechanisms underlying the postjunctional blockade induced by phenthonium [N-(4-phenyl) phenacyl 1-hyoscyamine] were investigated in mammalian and amphibian muscles. This muscarinic antagonist was previously shown to enhance specifically the spontaneous acetylcholine (ACh) release at concentrations that blocked neuromuscular transmission.2 in both rat diaphragm and frog sartorius muscles, phenthonium (Phen, 1-100 mu M) depressed the muscle twitches elicited by nerve stimulation (IC50: 23 mu M and 5 mu M, respectively), and blocked the nerve-evoked muscle action potential. the neuromuscular blockade was not reversed after incubation with neostigmine.3 Equal concentrations of Phen decreased the rate of rise and prolonged the falling phase of the directly elicited action potential in frog sartorius muscle fibres, indicating that the drug also affects the sodium and potassium conductance.4 Phen (50 and 100 mu M) protected the ACh receptor against alpha-bungarotoxin (BUTX) blockade in the mouse diaphragm allowing recording of endplate potentials and action potentials after 5 h wash with physiological salt solution.5 Phen (10-100 mu M) produced a concentration- and voltage-dependent decrease of the endplate current (e.p.c.), and induced nonlinearity of the current-voltage relationship. At high concentrations Phen also shortened the decay time constant of e.p.c (tau(e.p.c.)) and reduced its voltage sensitivity.6 At the same range of concentrations, Phen also reduced the initial rate of [I-125]-BUTX binding to junctional ACh receptors of the rat diaphragm (apparent dissociation constant = 24 mu M), the relationship between the degree of inhibition and antagonist concentration being that expected for a competitive mechanism.7 It is concluded that Phen affects the electrical excitability of the muscle fibre membrane, and blocks neuromuscular transmission through a mechanism that affects the agonist binding to its recognition site and ionic channel conductance of the nicotinic ACh receptor.
id UFSP_d251e424db4c037d1629272c86255de2
oai_identifier_str oai:repositorio.unifesp.br:11600/25917
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Souccar, Caden [UNIFESP]Lima-Landman, MTRBallejo, G.Lapa, Antonio José [UNIFESP]Universidade Federal de São Paulo (UNIFESP)2016-01-24T12:30:36Z2016-01-24T12:30:36Z1998-07-01British Journal of Pharmacology. Basingstoke: Stockton Press, v. 124, n. 6, p. 1270-1276, 1998.0007-1188http://repositorio.unifesp.br/handle/11600/25917http://dx.doi.org/10.1038/sj.bjp.070193210.1038/sj.bjp.0701932WOS:0000749650000341 the mechanisms underlying the postjunctional blockade induced by phenthonium [N-(4-phenyl) phenacyl 1-hyoscyamine] were investigated in mammalian and amphibian muscles. This muscarinic antagonist was previously shown to enhance specifically the spontaneous acetylcholine (ACh) release at concentrations that blocked neuromuscular transmission.2 in both rat diaphragm and frog sartorius muscles, phenthonium (Phen, 1-100 mu M) depressed the muscle twitches elicited by nerve stimulation (IC50: 23 mu M and 5 mu M, respectively), and blocked the nerve-evoked muscle action potential. the neuromuscular blockade was not reversed after incubation with neostigmine.3 Equal concentrations of Phen decreased the rate of rise and prolonged the falling phase of the directly elicited action potential in frog sartorius muscle fibres, indicating that the drug also affects the sodium and potassium conductance.4 Phen (50 and 100 mu M) protected the ACh receptor against alpha-bungarotoxin (BUTX) blockade in the mouse diaphragm allowing recording of endplate potentials and action potentials after 5 h wash with physiological salt solution.5 Phen (10-100 mu M) produced a concentration- and voltage-dependent decrease of the endplate current (e.p.c.), and induced nonlinearity of the current-voltage relationship. At high concentrations Phen also shortened the decay time constant of e.p.c (tau(e.p.c.)) and reduced its voltage sensitivity.6 At the same range of concentrations, Phen also reduced the initial rate of [I-125]-BUTX binding to junctional ACh receptors of the rat diaphragm (apparent dissociation constant = 24 mu M), the relationship between the degree of inhibition and antagonist concentration being that expected for a competitive mechanism.7 It is concluded that Phen affects the electrical excitability of the muscle fibre membrane, and blocks neuromuscular transmission through a mechanism that affects the agonist binding to its recognition site and ionic channel conductance of the nicotinic ACh receptor.Universidade Federal de São Paulo, Escola Paulista Med, Dept Pharmacol, Div Cellular Pharmacol, BR-04044020 São Paulo, BrazilUniversidade Federal de São Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, Ribeirao Preto, SP, BrazilUniversidade Federal de São Paulo, Escola Paulista Med, Dept Pharmacol, Div Cellular Pharmacol, BR-04044020 São Paulo, BrazilUniversidade Federal de São Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, Ribeirao Preto, SP, BrazilWeb of Science1270-1276engStockton PressBritish Journal of Pharmacologynicotinic receptornoncompetitive blockerionic channelendplate currentmuscarinic antagonistMechanism of neuromuscular blockade induced by phenthonium, a quaternary derivative of (-)-hyoscyamine, in skeletal musclesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP11600/259172023-01-12 21:39:42.13metadata only accessoai:repositorio.unifesp.br:11600/25917Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-01-13T00:39:42Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Mechanism of neuromuscular blockade induced by phenthonium, a quaternary derivative of (-)-hyoscyamine, in skeletal muscles
title Mechanism of neuromuscular blockade induced by phenthonium, a quaternary derivative of (-)-hyoscyamine, in skeletal muscles
spellingShingle Mechanism of neuromuscular blockade induced by phenthonium, a quaternary derivative of (-)-hyoscyamine, in skeletal muscles
Souccar, Caden [UNIFESP]
nicotinic receptor
noncompetitive blocker
ionic channel
endplate current
muscarinic antagonist
title_short Mechanism of neuromuscular blockade induced by phenthonium, a quaternary derivative of (-)-hyoscyamine, in skeletal muscles
title_full Mechanism of neuromuscular blockade induced by phenthonium, a quaternary derivative of (-)-hyoscyamine, in skeletal muscles
title_fullStr Mechanism of neuromuscular blockade induced by phenthonium, a quaternary derivative of (-)-hyoscyamine, in skeletal muscles
title_full_unstemmed Mechanism of neuromuscular blockade induced by phenthonium, a quaternary derivative of (-)-hyoscyamine, in skeletal muscles
title_sort Mechanism of neuromuscular blockade induced by phenthonium, a quaternary derivative of (-)-hyoscyamine, in skeletal muscles
author Souccar, Caden [UNIFESP]
author_facet Souccar, Caden [UNIFESP]
Lima-Landman, MTR
Ballejo, G.
Lapa, Antonio José [UNIFESP]
author_role author
author2 Lima-Landman, MTR
Ballejo, G.
Lapa, Antonio José [UNIFESP]
author2_role author
author
author
dc.contributor.institution.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Souccar, Caden [UNIFESP]
Lima-Landman, MTR
Ballejo, G.
Lapa, Antonio José [UNIFESP]
dc.subject.eng.fl_str_mv nicotinic receptor
noncompetitive blocker
ionic channel
endplate current
muscarinic antagonist
topic nicotinic receptor
noncompetitive blocker
ionic channel
endplate current
muscarinic antagonist
description 1 the mechanisms underlying the postjunctional blockade induced by phenthonium [N-(4-phenyl) phenacyl 1-hyoscyamine] were investigated in mammalian and amphibian muscles. This muscarinic antagonist was previously shown to enhance specifically the spontaneous acetylcholine (ACh) release at concentrations that blocked neuromuscular transmission.2 in both rat diaphragm and frog sartorius muscles, phenthonium (Phen, 1-100 mu M) depressed the muscle twitches elicited by nerve stimulation (IC50: 23 mu M and 5 mu M, respectively), and blocked the nerve-evoked muscle action potential. the neuromuscular blockade was not reversed after incubation with neostigmine.3 Equal concentrations of Phen decreased the rate of rise and prolonged the falling phase of the directly elicited action potential in frog sartorius muscle fibres, indicating that the drug also affects the sodium and potassium conductance.4 Phen (50 and 100 mu M) protected the ACh receptor against alpha-bungarotoxin (BUTX) blockade in the mouse diaphragm allowing recording of endplate potentials and action potentials after 5 h wash with physiological salt solution.5 Phen (10-100 mu M) produced a concentration- and voltage-dependent decrease of the endplate current (e.p.c.), and induced nonlinearity of the current-voltage relationship. At high concentrations Phen also shortened the decay time constant of e.p.c (tau(e.p.c.)) and reduced its voltage sensitivity.6 At the same range of concentrations, Phen also reduced the initial rate of [I-125]-BUTX binding to junctional ACh receptors of the rat diaphragm (apparent dissociation constant = 24 mu M), the relationship between the degree of inhibition and antagonist concentration being that expected for a competitive mechanism.7 It is concluded that Phen affects the electrical excitability of the muscle fibre membrane, and blocks neuromuscular transmission through a mechanism that affects the agonist binding to its recognition site and ionic channel conductance of the nicotinic ACh receptor.
publishDate 1998
dc.date.issued.fl_str_mv 1998-07-01
dc.date.accessioned.fl_str_mv 2016-01-24T12:30:36Z
dc.date.available.fl_str_mv 2016-01-24T12:30:36Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv British Journal of Pharmacology. Basingstoke: Stockton Press, v. 124, n. 6, p. 1270-1276, 1998.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/handle/11600/25917
http://dx.doi.org/10.1038/sj.bjp.0701932
dc.identifier.issn.none.fl_str_mv 0007-1188
dc.identifier.doi.none.fl_str_mv 10.1038/sj.bjp.0701932
dc.identifier.wos.none.fl_str_mv WOS:000074965000034
identifier_str_mv British Journal of Pharmacology. Basingstoke: Stockton Press, v. 124, n. 6, p. 1270-1276, 1998.
0007-1188
10.1038/sj.bjp.0701932
WOS:000074965000034
url http://repositorio.unifesp.br/handle/11600/25917
http://dx.doi.org/10.1038/sj.bjp.0701932
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv British Journal of Pharmacology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 1270-1276
dc.publisher.none.fl_str_mv Stockton Press
publisher.none.fl_str_mv Stockton Press
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764117134540800